studies in mice with a null mutation of the gene for orexin (19<IMG BORDER=1 WIDTH=8 HEIGHT=7 ALT="Go"
SRC="/icons/fig-down.gif">) or one of its receptors (20<IMG BORDER=1 WIDTH=8 HEIGHT=7 ALT="Go"
SRC="/icons/fig-down.gif">) as well as transgenic mice with a targeted ablation of orexin neurons (21<IMG BORDER=1 WIDTH=8 HEIGHT=7 ALT="Go"
SRC="/icons/fig-down.gif">) revealed severe disturbances of sleep and wakefulness, similar to narcoleptic symptoms in humans
